Prerpints.org logo
Preprint
Case Report

This version is not peer-reviewed.

Remission of Irritable Bowel Syndrome Achieved Through Combined Diet, Lifestyle Modification, and Yoga: A Case Report

Submitted:

28 February 2026

Posted:

03 March 2026

You are already at the latest version

Abstract
This report describes a 33-year-old male initially suspected of Inflammatory Bowel Disease (IBD) due to radiological findings, but finally diagnosed with Irritable Bowel Syndrome (IBS) based on the Rome IV criteria, normal colonoscopy findings and inflammatory biomarkers. When symptomatic pharmacotherapy for pain, constipation and heartburn alone did not bring lasting relief, he was referred for lifestyle therapy. Dietary, lifestyle advice, and physical activity are mainstay in the current guidelines on the management of IBS. However, beyond these generalities, patients receive little guidance on day-to-day decision making and essential elements of healthy living. We addressed the limitations in current guidelines on IBS by following the 21-point Health Building Guideline, along with Yoga and delivered through a seven-point protocol that uses the traffic light approach to promote and sustain behavioural changes in chronic diseases. After seven months of consistent adherence to intervention; following the traffic light approach, the patient achieved remission.
Keywords: 
irritable bowel syndrome
;  
yoga
;  
life style
;  
remission induction
;  
gastrointestinal microbiome
;  
brain-gut axis
;  
phytotherapy
;  
diet
;  
whole plant-based diet
;  
complementary therapies
;  
quality of life
;  
lifestyle
;  
non-pharmacological therapy
Subject: 
Medicine and Pharmacology  -   Gastroenterology and Hepatology

Introduction

Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by recurrent abdominal pain associated with altered bowel habits, in the absence of identifiable structural or biochemical abnormalities. Functional gastrointestinal disorders impact 40% of the global population, with IBS standing out at 14% due to its complexity, quality-of-life effects, and economic impact. cite:Arif2025
IBS is now widely understood as a multifactorial disorder. Its pathophysiology involves disruptions in the gut-brain axis, visceral hypersensitivity, gastrointestinal dysmotility, gut dysbiosis cite:DeFilippis2020, food intolerances, and psychosocial factors. cite:Canavan2014 A positive diagnostic approach allows early intervention and improved patient outcomes. Accurate diagnosis can be made using Rome IV criteria and ruling out diseases that present with similar symptoms . cite:Nathani2025 The Diagnostic Criteria (Rome IV) are recurrent abdominal pain, on an average at least 1 day per week in the last 3 months; with symptoms onset at least 6 months prior to diagnosis and two or more of the following: 1. Related to defecation, 2. Associated with a change in stool frequency and 3. Associated with a change in stool form/appearance. cite:Rome-IV The Rome IV diagnostic criteria have a sensitivity of 82.1% and specificity of 85.1%. cite:Arif2024 Recommended investigations are full blood count, C-reactive protein, celiac serology, and fecal calprotectin. If diarrhea is the predominant symptom, a colonoscopy with biopsies should be considered to rule out microscopic colitis. cite:Sperber2021 Underdiagnosis & mismanagement of IBS leading to excessive diagnostic tests and financial burden on patients is not uncommon.
Once the diagnosis is made, an empathetic approach is recommended to improve quality of life and symptom control, and reduce healthcare expenditure. The mainstays of treatment include patient education about the condition, dietary changes, soluble fibre, and antispasmodic drugs. cite:Ford2020 IBS management based on current guidelines cite:Lacy2021 follows a stepwise, patient-centred approach encompassing dietary, pharmacological, and psychological therapies. Dietary Interventions include a limited trial of a low-FODMAP diet. Soluble fibre is effective for global symptoms and abdominal pain, but insoluble fibre should be avoided. Food elimination diets based on IgG antibodies and gluten-free diets are not recommended. Pharmacological treatment is symptom dependent (constipation or diarrhea predominant) and consists of antispasmodics & peppermint oil, neuromodulators (Antidepressants) as a second line treatment, probiotics, psychological & behavioural gut-directed psychotherapy like cognitive behavioural therapy (CBT), gut-directed hypnotherapy, and mindfulness-based approaches are also suggested. IBS is a long-term condition with no known cure, which fluctuates in severity over time and can have a substantial impact on quality of life and ability to work and socialise. Yet there is evidence that common bioactive dietary components can be useful in its treatment. cite:DeFilippis2020 Still, there is limited evidence on remission of IBS through a comprehensive lifestyle medicine approach. cite:Shabbir2025 We attempt to bridge this gap.
Our patient’s main concerns were abdominal pain and altered bowel habits, predominantly constipation.

Patient Information

The patient, a 33-year-old male, is an industrial worker belonging to a lower socio-economic class. He presented in April, 2025 to the Gastrointestinal clinic with complaints of chronic constipation interspersed with brief episodes of loose stools with increased frequency, incomplete evacuation, bloating; defecation was consistently associated with lower abdominal pain and tenesmus. His symptoms had persisted for one year. The onset of symptoms was insidious and the progression was gradual. The color and odor of the stools were unremarkable. Notably, there was no history of melena, hematochezia, mucus in the stool, or nocturnal urgency. Associated symptoms included persistent heartburn, bloating, and flatulence. The patient denied nausea, vomiting, or icterus. His abdominal pain was gradual in onset and progressive in nature. It was described as cramping in character, primarily localized to the lower abdomen. The pain was typically aggravated post-prandially and relieved following defecation. There was no referred or radiating pain reported.
The patient’s medical history was negative for tuberculosis, asthma, diabetes mellitus or hypertension. There was no history of similar gastrointestinal illness among first-degree relatives.
His bladder habits were normal and his appetite remained adequate; however, he reported reduced sleep. There was no history of significant weight loss. The patient led a non-sedentary lifestyle with no history of smoking, alcohol consumption, or tobacco use.

Clinical Findings

The patient had a moderate build, was adequately nourished. On examination, he was afebrile, had no organomegaly, palpable abdominal mass, no tenderness per abdomen. His weight and blood pressure were within normal limits. (Table-1)

Diagnostic Assessment

Routine lab investigations were normal (Complete Blood Count, C-Reactive Protein, ESR). Thyroid Function Test, Iron Studies, Viral markers, Kidney Function Test were also normal. Fecal biomarkers (Fecal Calprotectin) were within normal limits.
Radiology: The patient had undergone a CT scan at the referring hospital on 27/3/2025, which showed diffuse circumferential wall thickening of the colon and ileocolic junction, suggesting Inflammatory Bowel Disease (IBD). When the initial management did not relieve his symptoms, a Colonoscopy was performed (20/11/2025), which revealed a completely normal mucosa from the rectum to the terminal ileum. (Figure)
The CT findings were not supported by clinical history (blood in stool) or inflammatory markers in blood. Hence, they were interpreted as “pseudothickening” due to colonic spasm or under-distension, and based on presentation and investigations and colonoscopy findings, the patient was finally diagnosed with IBS.
His Bristol Stool Scale was assessed to be 1 / 2.

Therapeutic Intervention

For the initial two months of presentation, the patient was managed exclusively in the Gastro clinic with symptomatic, pharmacological treatment with Proton Pump inhibitors (PPI), anti-colic drugs, Sucralfate, laxatives, and a course of antibiotics. Since the patient was not getting a lasting relief, he was referred to the Integrative Health Clinic (IHC) for lifestyle advice. For next seven months, the patient continued to visit both the clinics, continuing the symptomatic pharmacotherapy from the Gastro clinic, and starting the Lifestyle interventions of the IHC. For the most recent month (eighth month of practice), as the patient’s symptoms improved, he discontinued the former and remained on lifestyle therapy alone. At the time of writing, the patient reported near full improvement in symptoms for the past one month after a regular adherence to the lifestyle routine.
The interventions at the IHC Lifestyle clinic were the following:
  • Counseling emphasising the importance of lifestyle modification with foundations in complete exclusion of high-fat, high-sugar (HFHS) diet and Ultra-Processed Foods (UPFs). Instead, the patient was advised to follow a whole, plant-based diet, exercise (Yoga asanas), deep breathing (Pranayam) and to follow the circadian-aligned routine. The protocol followed was the Traffic light approach for diet and lifestyle changes - “Health Building Guidelines”. cite:Sarwal2026
  • Daily morning intake of a glass of lukewarm infusion of four spices viz Cumin, Coriander, Fenugreek & Cinnamon. These spices are known to have laxative properties, and reduce dyspepsia, bloating and flatulence and in addition exert anti-inflammatory effects.
  • Daily practice of Yoga asanas and Bhramari Pranayam for at least 30 minutes which help in stress reduction and better autonomic nervous system regulation. cite:Khajuria2024
  • For the benefit of the patient’s understanding, motivation and compliance, he was referred to a YouTube channel that first hand demonstrates each of the suggested lifestyle interventions. cite:SutraHealth2026

Follow-up and Outcomes

Following seven months of adherence to the lifestyle modifications, the patient reported complete resolution of lower abdominal pain, while bloating & flatulence reduced significantly. His stool consistency normalized and tenesmus was eliminated. (Bristol Stool Scale improved to type 3 from previous type 1/2). His overall quality of Life improved. The outcome of the treatment assessed after seven months using the IBS-SSS questionnaire is given in Table-2.
The patient gained some weight after achieving remission seven months into lifestyle therapy. (Table-3)

Discussion

Current guidelines on IBS across the world cite:Lacy2021 cite:NICE2026 focus on managing the symptoms, rather than remission and lack a clear direction for management of the condition - even on the specifics of diet beyond the FODMAP, lifestyle or exercise. Multiple best-practice recommendations in management of IBS cite:Chey2022 allude to the challenges that clinicians face in such cases and the limitations of current ACG guidelines. The wide variety of dietary advice and therapeutic agents recommended in IBS cite:Vasant2021 reflects the diversity of cases and difficulty in managing them.
Moreover, lifestyle advice has issues with patient compliance and consistency, which current guidelines do little to help. We followed the comprehensive Health Building Guideline that follows a traffic light approach to lifestyle along with its seven-point administration protocol which seamlessly helped in guiding and managing patients on their journey to a better lifestyle. cite:Sarwal2026
Our multimodal approach combining diet, lifestyle advice and yoga worked in achieving a remission largely by removing triggers and incorporating a favourable gut microbial modulation and working through the gut-brain axis. cite:Dale2023 By leaving food choices to his taste and judgment within broad groups, but with abundance of salad, fruits and vegetables, the “traffic light approach to lifestyle’’ guidelines provided patients the autonomy to individualize his treatment, which is necessary in IBS. cite:Capili2016 The Health Building lifestyle intervention that we followed is broader in scope, comprehensive, and acts at multiple organ systems (lungs, cardio-vascular, musculo-skeletal, neuro-endocrine, brain and the mind besides the gut) than the FODMAP diet which merely reduces certain difficult to digest carbohydrates.
There is preliminary evidence that culinary doses of spices might have prebiotic-like effects. Broader spice research (including coriander, cinnamon) indicates that polyphenol-rich spice mixtures can, even with short term use, modulate gut microbiome composition and potentially boost beneficial bacteria like Bifidobacterium in humans. cite:Khine2021
-
Cumin extract have been successful in symptom control in IBS patients in a case series cite:Agah2013
-
In pilot studies Carmint, a herbal preparation containing Coriandrum sativum, has been found effective in relieving abdominal pain and bloating in patients of IBS in a pilot study cite:Vejdani2006
-
Soluble dietary fiber galactomannan, derived from fenugreek seeds, has demonstrated the ability to foster regular bowel movements, and the regulation of intestinal flora. cite:Faisal2024 cite:Yao2020 Animal studies have shown that fenugreek alters the gut microbiome composition (e.g., increases certain beneficial bacterial taxa and microbiome diversity) in mice fed high-fat diets. cite:Jones2022 USDA has reported that “data from our lab shows that fenugreek significantly alters intestinal microbial populations, and reverses key Western diet-induced changes to gut microbiota” to propose a hypothesis that fenugreek induces physiologic resiliency via changes to intestinal microbiota by offsetting diet-induced gut dysbiosis cite:USDA2026
-
Aqueous cinnamon extract has shown to ameliorate bowel dysfunction and enteric 5-HT synthesis in IBS rats. cite:Yu2023
We supplemented our therapy with Yoga asanas and Bhramari Pranayama. Studies have shown Yoga to be as effective as a low-FODMAP diet in reducing visceral hypersensitivity by modulating the autonomic nervous system and reducing the “stress-induced” proinflammatory environment of the gut. cite:Schumann2018 cite:DSilva2022
The strengths in our case report are :
  • Diagnostic Rigor: Organic pathology was reasonably ruled out using colonoscopy and fecal calprotectin
  • Holistic, evidence based Management: Our case report showcases that a multi-modal, non-pharmacological but evidence based approach consisting of a whole plant-based diet, lifestyle, Yoga and deep breathing (Bhramari Pranayam) presented with a traffic light approach is successful in inducing remission of IBS.
  • Affordability, ease of administration and high compliance given its structured, yet flexible format place the patients in charge of their health to achieve remission.
  • Sustainabile, by keeping it simple, and self administered.
One limitation of our case report is that it is a single-Case, whose results may not be universally generalizable to all IBS patients. Since the patient continued on symptomatic pharmacotherapy for initial six months of lifestyle therapy, the former present as confounding factors. IBS being a chronic disease that takes time to resolve, its symptoms being distressing and affecting activities of daily living, patients may need pharmacotherapy for symptomatic relief.

Conclusion

This report demonstrates how a whole plant-based diet, Yoga, and lifestyle modifications can achieve remission in a chronic case of IBS. Just as IBS is a disease of multi-factorial aetiology, its management through a set of lifestyle interventions operates at multiple levels to eliminate triggers, and modulate the gut-brain axis. “The Traffic Light Approach” to lifestyle modifications combined with Yoga and Bhramari Pranayam warrants evaluation in larger, controlled studies to establish its efficacy and generalizability in achieving remission from IBS.

Patient Perspective

The patient expressed great satisfaction with the outcome of the treatment. He found the treatment practical and easy to follow. He appeared to have benefited physically, emotionally, socially, and financially. The treatment has helped him regain confidence, energy, and enthusiasm.

Ethics Approval

Being a case report, it was not considered necessary.

Declaration of Competing Interests

The corresponding author runs a free, publicly accessible YouTube channel to promote a healthy lifestyle, which was used by the patient and cited in this paper. The authors declare that they have no competing interests.

References

  1. Bin Arif, Taha; Ali, Syed Hasham; Bhojwani, Kapil Dev; Sadiq, Mahnoor; Siddiqui, Asad Ali; Ur-Rahman, Asad; Khan, Muhammad Zarrar; Hasan, Fariha; Shahzil, Muhammad. Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis. Eur. J. Gastroenterol. Hepatol. 2025, 37(12), 1314–1325. [Google Scholar] [CrossRef] [PubMed]
  2. De Filippis, Anna; Ullah, Hammad; Baldi, Alessandra; Dacrema, Marco; Esposito, Cristina; Garzarella, Emanuele Ugo; Santarcangelo, Cristina; Tantipongpiradet, Ariyawan; Daglia, Maria. Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment. Int. J. Mol. Sci. 2020, 21(14), 4929. [Google Scholar] [CrossRef] [PubMed]
  3. Canavan, Caroline; West, Joe; Card, Timothy. The epidemiology of irritable bowel syndrome. Clinical Epidemiology 2014, 6, 71. [Google Scholar] [CrossRef] [PubMed]
  4. Nathani, Rohit R.; Sodhani, Shreya; Goosenberg, Eric. Irritable Bowel Syndrome. StatPearls [Internet]; StatPearls Publishing, November 2025. Available online: https://www.ncbi.nlm.nih.gov/books/NBK534810.
  5. Rome-IV. Rome IV Criteria j The Rome Foundation, January 2026. Available online: https://theromefoundation.org/rome-iv/rome-iv-criteria (accessed on 23. Feb. 2026).
  6. Bin Arif, Taha; Ali, Syed Hasham; Sadiq, Mahnoor; Bhojwani, Kapil Dev; Hasan, Fariha; Rahman, Asad Ur; Khan, Muhammad Zarrar. S753 Meta-Analysis of Global Prevalence and Gender Distribution of Irritable Bowel Syndrome (IBS) Using Rome III and IV Criteria. Official journal of the American College of Gastroenterology j ACG 2024, 119(10S), S517. [Google Scholar] [CrossRef]
  7. Sperber, Ami D.; Bangdiwala, Shrikant I.; Drossman, Douglas A.; Ghoshal, Uday C.; Simren, Magnus; Tack, Jan; Whitehead, William E.; Dumitrascu, Dan L.; Fang, Xuicai; Fukudo, Shin; Kellow, John; Okeke, Edith; Quigley, Eamonn M. M.; Schmulson, Max; Whorwell, Peter; Archampong, Timothy; Adibi, Payman; Andresen, Viola; Benninga, Marc A.; Bonaz, Bruno; Bor, Serhat; Fernandez, Luis Bustos; Choi, Suck Chei; Corazziari, Enrico S.; Francisconi, Carlos; Hani, Albis; Lazebnik, Leonid; Lee, Yeong Yeh; Mulak, Agata; Rahman, M. Masudur; Santos, Javier; Setshedi, Mashiko; Syam, Ari Fahrial; Vanner, Stephen; Wong, Reuben K.; Lopez-Colombo, Aurelio; Costa, Valeria; Dickman, Ram; Kanazawa, Motoyori; Keshteli, Ammar Hassanzadeh; Khatun, Rutaba; Maleki, Iradj; Poitras, Pierre; Pratap, Nitesh; Stefanyuk, Oksana; Thomson, Sandie; Zeevenhooven, Judith; Palsson, Olafur S. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 2021, 160(1), 99–1143. [Google Scholar] [CrossRef]
  8. Ford, Alexander C.; Sperber, Ami D.; Corsetti, Maura; Camilleri, Michael. Irritable bowel syndrome. Lancet 2020, 396(10263), 1675–1688. [Google Scholar] [CrossRef]
  9. Lacy, Brian E.; Pimentel, Mark; Brenner, Darren M.; Chey, William D.; Keefer, Laurie A.; Long, Millie D.; Moshiree, Baha. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am. J. Gastroenterol. 2021, 116(1), 17–44. [Google Scholar] [CrossRef]
  10. Shabbir, Palwasha; Malik, Samina; Naveed, Manal; Anwar, Muhammad Farhan; Sheraz, Mateen; Waraich, Hassan Zahid. Remission of irritable bowel syndrome with lifestyle medicine. Pakistan Journal of Medical Sciences 2025, 41(7), 2156. [Google Scholar] [CrossRef]
  11. Sarwal, Rakesh; Pandey, Anil K.; Sood, Suruchi; Negi, Deepa. A traffic light approach to lifestyle change: Health building guideline for NCD outpatients in India. Journal of Family Medicine and Primary Care 2026, 15(1), 60. [Google Scholar] [CrossRef]
  12. Khajuria, Aayushi; Kumar, Amit; Joshi, Deepak; Kumaran, S. Senthil. Reducing Stress with Yoga: A Systematic Review Based on Multimodal Biosignals. International Journal of Yoga 2024, 16(3), 156. [Google Scholar] [CrossRef]
  13. SutraHealth. Sutra Health, February 2026. Available online: https://www.youtube. (accessed on 25. Feb. 2026).
  14. Recommendations j Irritable bowel syndrome in adults: diagnosis and management j Guidance j NICE, February 2026. Available online: https://www.nice.org.uk/guidance/cg61/chapter/ (accessed on 25. Feb. 2026).
  15. Chey, William D.; Hashash, Jana G.; Manning, Laura; Chang, Lin. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review. Gastroenterology 2022, 162(6), 1737–1745.e5. [Google Scholar] [CrossRef] [PubMed]
  16. Vasant, Dipesh H.; Paine, Peter A.; Black, Christopher J.; Houghton, Lesley A.; Everitt, Hazel A.; Corsetti, Maura; Agrawal, Anurag; Aziz, Imran; Farmer, Adam D.; Eugenicos, Maria P.; Moss-Morris, Rona; Yiannakou, Yan; Ford, Alexander C. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021, 70(7), 1214–1240. [Google Scholar] [CrossRef] [PubMed]
  17. Dale, Hanna Fjeldheim; Lorentzen, Sissi Christiane Stove; Mellin-Olsen, Tonje; Valeur, Jørgen. Dietmicrobiota interaction in irritable bowel syndrome: looking beyond the low-FODMAP approach. Scand. J. Gastroenterol. 2023. [Google Scholar] [CrossRef] [PubMed]
  18. Capili, Bernadette; Anastasi, Joyce K.; Chang, Michelle. Addressing the Role of Food in Irritable Bowel Syndrome Symptom Management. journal for nurse practitioners: JNP 2016, 12(5), 324. [Google Scholar] [CrossRef]
  19. Khine, Wei Wei Thwe; Haldar, Sumanto; De Loi, Shou; Lee, Yuan-Kun. A single serving of mixed spices alters gut microflora composition: a dose–response randomised trial. Sci. Rep. 2021, 11(11264), 11264. [Google Scholar] [CrossRef]
  20. Agah, Shahram; Mehdi Taleb, Amir; Moeini, Reyhane; Gorji, Narjes; Nikbakht, Hajar. Cumin Extract for Symptom Control in Patients with Irritable Bowel Syndrome: A Case Series. Middle East Journal of Digestive Diseases 2013, 5(4), 217. Available online: https://pmc.ncbi.nlm.nih.gov/articles/PMC3990147.
  21. Vejdani, Reyhaneh; Shalmani, Hamid Reza Mohaghegh; Mir-Fattahi, Mina; Sajed-Nia, Faranak; Abdollahi, Morteza; Zali, Mohammad Reza; Alizadeh, Amir Houshang Mohammad; Bahari, Ali; Amin, Gholamreza. The efficacy of an herbal medicine, carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: A pilot study. Digestive Diseases and Sciences 2006, 51(8), 15011507. [Google Scholar] [CrossRef]
  22. Faisal, Zargham; Irfan, Rushba; Akram, Noor; Manzoor, Hafiz Muhammad Irfan; Aabdi, Mohib Ali; Anwar, Muhammad Junaid; Khawar, Sharjeel; Saif, Asifa; Shah, Yasir Abbas; Afzaal, Muhammad; Desta, Derese Tamiru. The multifaceted potential of fenugreek seeds: From health benefits to food and nanotechnology applications. Food Science amp; Nutrition 2024, 12(4), 22942310. [Google Scholar] [CrossRef]
  23. Yao, Dongning; Zhang, Bingyu; Zhu, Jianfan; Zhang, Qianru; Hu, Yuanjia; Wang, Shengpeng; Wang, Yitao; Cao, Hui; Xiao, Jianbo. Advances on application of fenugreek seeds as functional foods: Pharmacology, clinical application, products, patents and market. Crit. Rev. Food Sci. Nutr. 2020, arXiv:3128678960(14), 2342–2352. [Google Scholar] [CrossRef]
  24. Jones, Katarina A.; Richard, Allison J.; Salbaum, J. Michael; Newman, Susan; Carmouche, Richard; Webb, Sara; Bruce-Keller, Annadora J.; Stephens, Jacqueline M.; Campagna, Shawn R. Cross-Omics Analysis of Fenugreek Supplementation Reveals Beneficial Effects Are Caused by Gut Microbiome Changes Not Mammalian Host Physiology. Int. J. Mol. Sci. 2022, arXiv:3540901423(7), 3654. [Google Scholar] [CrossRef]
  25. FENUGREEK; GUT MICROBIOTA; AND RESILIENCY TO WESTERN DIET j National Agricultural Library, February 2026. Available online: https://www.nal.usda.gov/research-tools/ (accessed on 26. Feb. 2026).
  26. Yu, Lijuan; Huang, Chunhua; Yang, Wei; Ren, Zhenxing; Li, Lifeng; Cheng, Huiyuan; Lin, Chengyuan; Zhai, Lixiang; Ning, Ziwan; Wong, Hoileong Xavier; Han, Quanbin; Jia, Wei; Bian, Zhaoxiang; Zhao, Ling. Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats. Front. Pharmacol. 2023, 13, 1010484. [Google Scholar] [CrossRef]
  27. Schumann, D.; Langhorst, J.; Dobos, G.; Cramer, H. Randomised clinical trial: yoga vs a low-FODMAP diet in patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 2018, 47(2), 203–211. [Google Scholar] [CrossRef]
  28. D’Silva, Adrijana; Marshall, Deborah A.; Vallance, Jeff K.; Nasser, Yasmin; Rajagopalan, Vidya; Szostakiwskyj, Jessie H.; Raman, Maitreyi. Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial. Am. J. Gastroenterol. 2022, 118(2), 329. [Google Scholar] [CrossRef]
Table 1. Case therapy timeline.
Table 1. Case therapy timeline.
Date Department visited Investigations Therapy Outcome
25/3/2025 G eneral Medicine Vit-D3, Multivitamins, Pentoprazole No relief
2/4/2025 Gastroenterology
Diagnosed as:
Inflammatory bowel disease, Non-infective gastroenteritis and colitis, unspecified		 - Hepatitis B,C,E antigen, HIV
- Stool for occult blood
- Stool Culture For Carriers Of Salmonella
All termed negative		 Cyclopam Tablet
Pentaprazole
Sucral Syp		 No relief
15/4/2025 Gastroenterology Isabgol Husk, Lactulose Syp.
Meftal Spas , Rifagut 550 Tab.		 No relief
30/4/2025 Gastroenterology Cyclopam MF Tab., Lactulose Syp.
Rifaximin Caps, Smooth Relief Granules
Pentopen DSR		 No relief
6/6/2025
25/7/2025
2/9/2025
8/10/2025
30/10/2025
20/11/2025
9/12/2025
13/1/2026		 Gastroenterology




Final diagnosis of IBS after colonoscopy.		 8/10/2025:
CBC
CRP
ESR
Stool routine,
stool microscopy
All returned normal		 - PPI, Antacid, Multi-vitamins
- Sucralfate
- Anti-emetic (Domperidone)
- Anti-spasmiotic (anti-cholinergic)
-Anxiolytic: Chlordiazepoxide
-Lactulose, Dulcolax (for constipation)
- Pre-probiotic, Pro-biotic like Bifilac
- Antibiotics (Rifaximin)		 No relief
6/6/2025 Integrative Health Clinic (IHC) none Presumptive Management started on
Diet, Lifestyle advice and Yoga.
-Calcium Carbonate, Zinc, Mg oxide, Vit. D3; Ferrous fumarate,, Folic acid with multi-vitamins 		No relief
9/12/2025 IHC CRP, ESR, Hba1c
All found normal		 Diet, Lifestyle advice and Yoga practice + Nurostar Gold RF Caps. Some relief
13/1/2026
14/2/2026		 IHC Repeated Diet, Lifestyle advice and Yoga practice. Calcium, Iron and Multi-Vitamin Full relief
Table 2. Pre and Post Treatment status on IBS-SSS parameters.
Table 2. Pre and Post Treatment status on IBS-SSS parameters.
Parameter (0-100) Pre intervention Post Intervention
Pain severity 50 0
Pain Frequency 40 0
Bloating 50 20
Bowel Dissatisfaction 60 10
Life Interference 50 10
Total 250
(Moderate)		 40
(Remission)
Total Score interpretation: Mild: 75 - 175, Moderate: 175-300, Severe: > 300, Remission: < 75.
Table 3. Vitals during IHC Visits (* Height of patient : 167 cms).
Table 3. Vitals during IHC Visits (* Height of patient : 167 cms).
Visit Date Weight BMI* Blood Pressure
9/12/2025 70.2 25.17 125/84
13/1/2026 71.8 25.74 136/83
14/2/2026 71.6 25.67 129/84
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
bsky
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated